RewordedRisk Factors
Changes in legal or regulatory requirements (such as new product safety requirements, extended producer responsibility requirements, revised regulatory requirements for the sourcing, processing processing, packaging and packaging labeling of products, and requirements to restrict or phase-out certain ingredients, chemicals and ozone-depleting substances or otherwise regulating greenhouse gas emissions), or evolving interpretations of existing legal or regulatory requirements, may result in increased compliance cost, capital expenditures and other financial obligations including costs to upgrade, phase out, modify or replace products or equipment that could adversely affect our business, financial condition and results of operations.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedRisk Factors
Such inflation may also reduce our profit margins and earnings if there is a lag between when costs increase and when we are able to pass it along to customers on all or if a portion of such product cost increases cannot be passed on along to customers because they resist paying higher prices. customers.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedRisk Factors
Ensuring Maintaining a good reputation and public confidence in the safety safety, quality and integrity of the products we produce and distribute is are critical to our business, particularly in selling our private label products, and to maintaining our good reputation. products.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedRisk Factors
For example, the Company completed its most recent annual impairment assessment for goodwill and indefinite-lived intangible assets as of the first day of the third quarter of fiscal year 2024 with no impairments noted. 2025, which resulted in a $13 million impairment during the fiscal year ended December 27, 2025.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedRisk Factors
A variety of factors could cause us not to realize expected cost savings, including, among others, delays in the anticipated timing of activities related to our cost savings initiatives, lack of sustainability in cost savings over time, and unexpected costs associated with operating our business.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedRisk Factors
Although our purchasing volume can provide an advantage when dealing with suppliers, suppliers may not provide the foodservice products and supplies we need in the quantities and at the time and prices requested.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedRisk Factors
Consumer eating habits could be affected by a number of factors, including changes in attitudes regarding diet and health, changes to nutritional guidelines or other regulatory or governmental action, advancement of pharmaceutical therapies, new information regarding the health effects of consuming certain foods of or shifts away from carbon-intensive products.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedRisk Factors
Furthermore, as a government contractor, we are subject to oversight by the Department of Labor’s Office of Federal Contract Compliance Programs, which reviews our employment practices including affirmative action and non-discrimination based on race, sex and disability, among other characteristics. practices.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedRisk Factors
GPOs act as agents on behalf of their members by negotiating pricing, delivery, and other terms with us. us, and we have experienced some pricing pressure from customers associated with a GPO.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedRisk Factors
Negative publicity from product recalls, instances of food-borne illness, about the Company or alleged food tampering our products may adversely impact our reputation and business.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedRisk Factors
Potential actions by activist stockholders may interfere with our ability to execute our strategic plans; create perceived uncertainties as to the future direction of our business or strategy; cause uncertainty with our regulators; make it more difficult to attract and retain qualified personnel; and adversely affect our relationships with our existing and potential customers, suppliers and other business partners.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedRisk Factors
We face risks related to labor relations, relations and increased labor costs and the availability of qualified labor, any of costs, which could have an adverse effect on our business, financial condition and results of operations.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
AddedMD&A
($ in millions) Debt Description Maturity Interest Rate as of December 27, 2025 Carrying Value as of December 27, 2025 Carrying Value as of December 28, 2024 ABL Facility December 7, 2027 5.41% $ 429 $ 223 2021 Incremental Term Loan Facility (net of $1 and $0 of unamortized deferred financing costs, respectively)(1) November 22, 2028 5.67% 609 610 2024 Incremental Term Loan Facility (net of $7 and $8 of unamortized deferred financing costs, respectively) October 3, 2031 5.67% 712 717 Unsecured Senior Notes due 2028 (net of $3 and $4 unamortized deferred financing costs, respectively) September 15, 2028 6.88% 497 496 Unsecured Senior Notes due 2029 (net of $4 and $5 of unamortized deferred financing costs, respectively) February 15, 2029 4.75% 896 895 Unsecured Senior Notes due 2030 (net of $2 and $3 of unamortized deferred financing costs, respectively) June 1, 2030 4.63% 498 497 Unsecured Senior Notes due 2032 (net of $4 and $4 of unamortized deferred financing costs, respectively) January 15, 2032 7.25% 496 496 Unsecured Senior Notes due 2033 (net of $2 and $4 of unamortized deferred financing costs, respectively) April 15, 2033 5.75% 498 496 Obligations under financing leases(2) 2026–2033 1.26% -8.31% 557 490 Other debt January 1, 2031 5.75% 8 8 Total debt(2) 5,200 4,928 Current portion of long-term debt (137) (109) Long-term debt $ 5,063 $ 4,819 (1) The 2021 Incremental Term Loan Facility was refinanced on October 3, 2024 as further discussed below. (2) For the fiscal year ended 2024, obligations under financing leases excludes financing leases classified as held for sale in relation the Freshway divestiture. Refer to Note 5, Acquisitions and Divestitures, for additional information.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RemovedMD&A
On June 5, 2024, the Company announced it intends to explore the potential sale of its assets and liabilities related to CHEF’STORE wholesale restaurant supply business and, if a sale is completed, then entirely focus on delivered broadline operations. As of December 28, 2024, the Company is in the process of exploring this sale which has not met held for sale criteria in the current year.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
The aggregate carrying value of our indebtedness was $4,928 million, net of $28 million of unamortized deferred financing costs, as of December 28, 2024.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
The Company’s 6.875% Senior Notes due 2028 (the “Unsecured Senior Notes due 2028”) had an outstanding balance of $496 million, net of $4 million of unamortized deferred financing costs, as of December 28, 2024.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
The Company’s 4.750% Senior Notes due 2029 (the “Unsecured Senior Notes due 2029”), had an outstanding balance of $895 million, net of $5 million of unamortized deferred financing costs, as of December 28, 2024.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
The Company’s 4.630% Senior Notes due 2030 (the “Unsecured Senior Notes due 2030”) had an outstanding balance of $497 million, net of $3 million of unamortized deferred financing costs, as of December 28, 2024.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
The Company’s 7.250% Senior Notes due 2032 (the “Unsecured Senior Notes due 2032”) had an outstanding balance of $496 million, net of $4 million of unamortized deferred financing costs, as of December 28, 2024.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
The Company’s 5.75% Senior Notes due 2033 (the “Unsecured Senior Notes due 2033”) had an outstanding balance of $496 million net of $4 million of unamortized deferred financing costs, as of December 28, 2024.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
The 2021 Incremental Term Loan Facility had a carrying value of $610 million, with no unamortized deferred financing costs, as of December 28, 2024.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
The 2024 Incremental Term Loan Facility borrowed in October 2024 had a carrying value of $717 million, net of $8 million of unamortized deferred financing costs, as of December 28, 2024.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
Our fair value estimates of the brand name and trademark indefinite-lived intangible assets are based on a relief from royalty method, including key assumptions such as the long-term growth rates of future revenues, the royalty rate for such revenue, and a discount rate. The fair value of each intangible asset is determined for comparison to the corresponding carrying value. If the carrying value of the asset exceeds its fair value, an impairment loss is recognized in an amount equal to the excess.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RewordedMD&A
(i) aggregate acquisition, integration related costs and planned divestiture costs of $32 million for fiscal year 2025, $22 million for fiscal year 2024, 2024 and $41 million for fiscal year 2023 and $22 million for fiscal year 2022 (ii) CEO sign on bonus of $3 million for fiscal year 2023 and (iii) contested proxy and related legal and consulting other gains, losses or costs that we are permitted to add back for purposes of $21 million for fiscal year 2022; calculating Adjusted EBITDA under certain agreements governing our indebtedness.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedMD&A
Restructuring activity and asset impairment charges(1) 33 25 14 12 Share-based compensation expense (2) 83 63 56 45 LIFO reserve adjustment(3) adjustments(3) 65 61 (1) 147 Loss on extinguishment of debt(4) — 10 21 — Recognition of net actuarial loss for pension settlement(5) — 124 — — Business transformation costs(6) 48 39 28 52 Business acquisition, integration related costs, divestitures and other(7) 38 22 44 66 Adjusted EBITDA and Adjusted EBITDA margin 1,932 4.9% 1,741 4.6% 1,559 4.4% 1,310 3.8% Depreciation expense (406) (384) (349) (327) Interest expense—net (305) (315) (324) (255) Income tax provision, as adjusted(8) (305) (272) (228) (190) Adjusted Net Income $ 916 $ 770 $ 658 $ 538 Cash flow Cash flows from operating activities $ 1,369 $ 1,174 $ 1,140 $ 765 Proceeds from sales of property and equipment 6 3 10 10 Capital expenditures (410) (341) (309) (265) Free Cash Flow $ 965 $ 836 $ 841 $ 510
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedMD&A
(1) more quality More Quality products, including our large portfolio of exclusive brands, Exclusive Brands, (2) more tools, More Tools, centering on our MOXē MOXē® business platform, (3) more support from our sellers and our team of experts and lastly, (4) more deliveries, (3) More Deliveries, enabled by our traditional broadline services services, Pronto® program and Pronto™ program. convenient delivery options.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedMD&A
Distribution, selling and administrative costs 5,632 5,412 5,117 4,886 Restructuring activity and asset impairment charges 33 23 14 12 Total operating expenses 5,665 5,435 5,131 4,898 Operating income 1,199 1,099 1,017 594 Other expense (income)—net (income) expense—net (4) 6 (6) (22) Interest expense—net 305 315 324 255 Loss on extinguishment of debt — 10 21 — Recognition of net actuarial loss for pension settlement — 124 — — Income before income taxes 898 644 678 361 Income tax provision 222 150 172 96 Net income 676 494 506 265 Series A convertible preferred stock dividends — — (7) (37) Net income available to common shareholders $ 676 $ 494 $ 499 $ 228 Net income per share:
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedMD&A
The increase was Total operating expenses increased $230 million, or 4.2%, to $5,665 million in fiscal year 2025, primarily as a result of an increase in total case volume, volume and higher distribution costs, reflecting increased labor distribution, selling and administrative costs, partially offset by continued distribution productivity improvement as well as actions to streamline administrative processes and costs.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedMD&A
Total Financial Highlights—Total case volume increased 4.2% 1.0% compared to the prior year driven by a 4.4% 3.3% increase in independent restaurant case volume, a 5.7% 4.4% increase in healthcare volume, volume and a 2.1% 2.9% increase in hospitality volume and volume, partially offset by a 3.2% increase 3.5% decrease in chain volume.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedMD&A
Cash flows used in investing activities in fiscal years 2025 and 2024 and 2023 included cash expenditures of $341 $410 million and $309 $341 million, respectively, and related to investments in information technology, new construction and expansion of distribution facilities and property and equipment for fleet replacement. and construction of and improvements to distribution facilities.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedMD&A
In the quarter ending December 28, 2024, we entered into We held approximately $362 million and $58 million of surety bonds, bonds as of December 27, 2025 and December 28, 2024, respectively, primarily in favor of certain commercial insurers to secure obligations with respect to our insurance programs.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedMD&A
Fiscal Year 2025 2024 2023 2022 (in millions) Net income available to common shareholders and net income margin $ 676 1.7% $ 494 1.3% $ 499 1.4% $ 228 0.7% Series A convertible preferred stock dividends — — (7) (37) Net income and net income margin 676 1.7% 494 1.3% 506 1.4% 265 0.8% Interest expense—net 305 315 324 255 Income tax provision 222 150 172 96 Depreciation expense 406 384 349 327 Amortization expense 56 54 46 45 EBITDA and EBITDA margin 1,665 4.2% 1,397 3.7% 1,397 3.9% 988 2.9% Adjustments:
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedMD&A
Fiscal Year 2025 2024 2023 (in millions) Net income $ 676 $ 494 $ 506 Changes in operating assets and liabilities 5 18 117 Other adjustments 688 662 517 Net cash provided by operating activities 1,369 1,174 1,140 Net cash used in investing activities (497) (552) (495) Net cash used by in financing activities (890) (831) (587) Net increase in cash, cash equivalents and restricted cash (18) (209) 58 Cash, cash equivalents and restricted cash—beginning of year 59 269 211 Cash, cash equivalents and restricted cash—end of year $ 41 $ 60 $ 269
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedMD&A
Financing activities in fiscal year 2024 2025 also included $948 $926 million of common stock repurchased, exclusive of approximately $10 $8 million of fees, commissions and the related 1% of excise tax under the Amended Original Share Repurchase Program and the May 2025 Share Repurchase Program, $50 million of unsettled accelerated share repurchases, $28 million of proceeds received from stock purchases under our employee stock purchase plan and $15 $6 million of proceeds from the exercise of employee stock options, which were offset by $21 $38 million of employee tax withholdings paid in connection with the vesting of stock awards.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new
RewordedMD&A
Our LIFO method of inventory costing resulted in an expense of $65 million in fiscal year 2025, compared to an expense of $61 million in fiscal year 2024, compared to a gain of $1 million in fiscal year 2023. 2024.
Read it in 10-K Feb 12, 2026 at sec.govopen_in_new